Abiopharma

🔍 Deaton John A. (Executive)

Company: HOME DEPOT, INC. (HD)

Report Date: 2026-03-24

Detailed Transactions and Holdings:

• Sold 155 shares of $.05 Common Stock at $330.91 per share (Direct)
  Date: 2026-03-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 13,974.01 | transaction_form_type: 4
• Acquired 2,467 shares of $.05 Common Stock (Direct)
  Date: 2026-03-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 16,441.01 | transaction_form_type: 4 | Footnotes: F1
• Acquired 6,451 shares of Employee Stock Options at $332.51 per share (Derivative)
  Date: 2026-03-25 | Code: A | Expires: 2036-03-24 | equity_swap_involved: 0 | shares_owned_after: 6,451.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The performance-based restricted shares were issued under The Home Depot, Inc. Omnibus Stock Incentive Plan, as amended and restated May 19, 2022, and vest 50% after 30 months and the remaining 50% after 60 months. The 2026 shares will be forfeited if FY2026 Company operating profit is not at least 90% of the target established under the 2026 Management Incentive Plan.
• F2: The stock options were issued under The Home Depot, Inc. Omnibus Stock Incentive Plan, as amended and restated May 19, 2022 and vest annually in 25% increments beginning on the second anniversary of the grant date.